SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001140361-24-022976
Filing Date
2024-04-29
Accepted
2024-04-29 16:22:28
Documents
13
Period of Report
2024-06-13

Document Format Files

Seq Description Document Type Size
1 DEF 14A ny20027192x1_def14a.htm DEF 14A 868238
2 ny20027192x1_image1.jpg GRAPHIC 5862
3 ny20027192x1_image10.jpg GRAPHIC 104243
4 ny20027192x1_image11.jpg GRAPHIC 32547
5 ny20027192x1_image12.jpg GRAPHIC 108667
6 ny20027192x1_image2.jpg GRAPHIC 10987
7 ny20027192x1_image3.jpg GRAPHIC 203853
8 ny20027192x1_image4.jpg GRAPHIC 52071
9 ny20027192x1_image5.jpg GRAPHIC 134785
10 ny20027192x1_image6.jpg GRAPHIC 209570
11 ny20027192x1_image7.jpg GRAPHIC 446994
12 ny20027192x1_image8.jpg GRAPHIC 145166
13 ny20027192x1_image9.jpg GRAPHIC 38640
  Complete submission text file 0001140361-24-022976.txt   2927763
Mailing Address 955 CHESTERBROOK BOULEVARD SUITE 110 CHESTERBROOK PA 19087
Business Address 955 CHESTERBROOK BOULEVARD SUITE 110 CHESTERBROOK PA 19087 6103548840
TREVENA INC (Filer) CIK: 0001429560 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36193 | Film No.: 24891221
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)